Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-04-000603
Filing Date
2004-02-25
Accepted
2004-02-25 11:51:09
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ten-k.txt 10-K 214677
3 EXHIBIT 10.11 ex10-11.txt EX-10 1856
4 EXHIBIT 10.12 ex10-12.txt EX-10 2213
5 EXHIBIT 10.13 ex10-13.txt EX-10 22582
6 EXHIBIT 10.14 ex10-14.txt EX-10 1845
7 EXHIBIT 23.1 ex23-1.txt EX-23 970
8 EXHIBIT 31.1 ex31-1.txt EX-31 3453
9 EXHIBIT 31.2 ex31-2.txt EX-31 3373
10 EXHIBIT 32.1 ex32-1.txt EX-32 1463
11 EXHIBIT 32.2 ex32-2.txt EX-32 1417
  Complete submission text file 0000950116-04-000603.txt   256484
Mailing Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422
Business Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422 2152836850
INKINE PHARMACEUTICAL CO INC (Filer) CIK: 0000929547 (see all company filings)

EIN.: 133754005 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25572 | Film No.: 04626625
SIC: 2834 Pharmaceutical Preparations